Programming - Hypertension Scientific Sessions

Save the date!
October 7-11, 2026
Hyatt Regency Crystal City | Arlington, Virginia

Hypertension 2026 Schedule-at-a-Glance

Wednesday, Oct. 7 Activities
Time	Activity
7:00 pm to 9:00 pm	Opening Member Reception and Networking Session (Free to attend, but please add a ticket to registration)

Thursday, Oct. 8 Activities
Time	Activity
7:30 am to 9:00 am	Session 1 Welcome Remarks and Keynotes American Heart Association Presidential Remarks Manesh Patel, MD, FAHA Welcome Remarks Jane F. Reckelhoff, PhD, FAHA \| Chair, Council on Hypertension Steven D. Crowley, MD \| Chair, Hypertension 2026 Scientific Sessions Program Committee Metabolic Reprogramming via HIF-1α to Confront Kidney and Cardiovascular Disease Volker Haase, MD HIF-2α inhibition and Pheochromocytoma/Paraglioma Camilo Jimenez Vasquez, MD
9:00 am to 10:00 am	Session 2 Aldosterone: Biology and Recent Clinical Trials Recent Clinical Trials Jamie Dwyer, MD Mechanisms for disrupting aldosterone signals to afford protection in hypertension and CVD David Ellison, MD
10:00 am to 10:30 am	Break
10:30 am to 12:00 pm	Session 3 - Concurrent Sessions A, B and C (Oral Abstract Presentations)
12:00 pm to 1:00 pm	Session 4 Meet the Keynote Speaker Networking Event (Attendance is limited)
12:00 pm to 1:30 pm	Lunch On Your Own
1:30 pm to 2:00 pm	Session 5 Harriet Dustan Award Lecture
2:00 pm to 3:00 pm	Session 6 Macula Densa Imaging macula densa function in blood pressure regulation Janos Peti-Peterdi, MD, PhD The macula densa’s role in mechanisms of AKI and resulting CKD Ruisheng Liu, MD, PhD
3:00 pm to 3:30 pm	Break
3:30 pm to 5:30 pm	Session 7 Concurrent A and B Trainee Advocacy Committee Oral Abstract Sessions Concurrent C (Clinical Track Sessions)
5:30 pm to 7:00 pm	Poster Session 1 and Reception Includes the TAC Poster Competition
7:00 pm to 8:00 pm	Mid-Career Mentorship Networking Roundtables

Friday, Oct. 9 Activities
Time	Activity
7:00 am to 7:45 am	Inside the AHA's Research Enterprise: Grant Funding and Other Opportunities
8:00 am to 9:00 am	Session 8 Cognition and Dementia in Hypertension Basic and immune mechanisms of cognitive impairment in hypertension Daniela Carnevale, PhD Cerebral small vessel disease and dementia in human hypertension Rebecca Gottesman, MD, PhD
9:00 am to 13:00 am	Poster Session 2 And Breakfast Reception
10:30 am to 12:00 pm	Session 9 Concurrent Sessions A, B (Oral Abstract Sessions)
12:00 pm to 1:00 pm	TAC CHAMP Lunch Event (By Invitation)
12:00 pm to 1:30 pm	Lunch On Your Own
1:30 pm to 3:00 pm	Session 10 Concurrents A and B (Oral Abstract Sessions) Concurrent C (Clinical Track Session)
3:00 pm to 3:30 pm	Break
3:30 to 4:45 pm	Session 11 Annual Hypertension Awards Session
4:45 pm to 5:15 pm	Session 12 Lewis K. Dahl Memorial Lecture Arthur C. Corcoran Memorial Lecture
7:00 pm to 10:00 pm	Trainee Advocacy Mixer Event

Saturday, Oct. 10 Activities
Time	Activity
7:30 am to 8:00 am	Session 13 Donald Seldin Lecture
8:00 am to 9:00 am	Session 14A Council on Kidney in Cardiovascular Disease Early Career Session Session 14B Clinical Track Session
9:00 am to 10:00 am	Session 15 Concurrent A, B (Oral Abstract Sessions) Concurrent C (Clinical Track Sessions)
10:00 am to 10:30 am	Break
10:30 am to 12:00 pm	Session 16 Concurrent A Hypertension Journal Cases
12:00 to 1:00 pm	*Meet the Hypertension* Editors Networking Event**
12:00 to 1:30 pm	Lunch On your Own
1:30 pm to 3:00 pm	Session 17 Concurrent A and B (Oral Abstract Sessions) Concurrent C (Clinical Track Session)
3:00 pm to 3:30 pm	Break
3:30 pm to 4:30 pm	Session 18 Council on Hypertension Mid-Career Award for Research Excellence Lecture KCVD Mid-Career Achievement Award Lecture
4:30 pm to 5:30 pm	Session 19 Concurrent A and B (Oral Abstract Sessions) Concurrent C (Clinical track Session)
5:45 pm to 6:15 pm	Session 20 Excellence Award for Hypertension Research
7:00 pm to 10:00 pm	Hypertension Council Gala Dinner

Sunday, Oct. 11 Activities
Time	Activity
8:00 am to 9:30 am	Session 21 Circadian Regulation of Cardiometabolic Health The effects of time-restricted feeding on cardiovascular disease in obesity Jennifer Pollock, PhD Key clinical research: Role of Circadian Regulation in Cardiometabolic Health and Disease Risk Kristen Knutson, PhD BMAL1, aldosterone, and sex differences in blood pressure regulation Michelle Gumz, PhD
9:30 am to 10:00 am	Break
10:00 am to 11:30 am	Session 22 Concurrent Sessions A and B (Oral Abstract Presentations) Concurrent C (Clinical Track Session)
11:30 am to 12:00 pm	Session 23 Closing Keynote Lecture Thu Le, MD, FAHA Immediate Past Chair, Council on Kidney in Cardiovascular Disease

About This Meeting

Hypertension 2025 Scientific Sessions is considered the premier scientific meeting on the subject in the world. A collaborative effort between the Council on Hypertension and the Council on the Kidney in Cardiovascular Disease, the science submitted to this conference continues to bring us the most up to date developments on our understanding of: the causes of hypertension; its relationship to stroke, cardiac disease and kidney dysfunction; and the most effective means for detecting, evaluating and treating high blood pressure across diverse populations.

This year's programming also includes:

Recent Advances sessions and lectures on cutting-edge science, followed by oral abstract presentations
Clinical Science/Clinical Practice track
Primary Care track
Oral abstract sessions highlighting Early Career oral abstract presentations
Networking sessions
Trainee Advocacy Committee (TAC) Poster session and competition
Award Lecture sessions

Learning Objectives

Discuss recent advances and emerging experimental models in hypertension and kidney disease.
Summarize findings from recent clinical trials and the impact on future treatment and/or management of hypertensive and kidney-related disorders.
Describe new therapeutic options and technologies for patients with hypertension and kidney disease.
Describe the most up-to-date clinical guideline recommendations for the prevention, diagnosis, and management of hypertension and kidney disease.